Basecamp Wealth Advisors’s Avidity Biosciences RNAM Stock Holding History

Basecamp Wealth Advisors’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-754	Closed	-$54.4K	–	2139
2025 Q4	$54.4K	Buy	+754	New	+$48.7K	0.01%	507

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Basecamp Wealth Advisors's RNAM Position: Q1 2026 in Review

Basecamp Wealth Advisors sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 754 shares — an estimated $54.4K sold.

Basecamp Wealth Advisors first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $54.4K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Basecamp Wealth Advisors reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Basecamp Wealth Advisors sold 754 Avidity Biosciences shares in Q1 2026, an estimated $54.4K.
Basecamp Wealth Advisors first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Basecamp Wealth Advisors's Avidity Biosciences position peaked at $54.4K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q1 2026, filed 24 Jun 2026.